RAGE: Developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 6, 2008, Pages

  Reynolds, Paul R ^a,c   Kasteler, Stephen D ^a   Cosio, Manuel G ^b   Sturrock, Anne ^a   Huecksteadt, Tom ^a   Hoidal, John R ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Disease; Early growth response gene 1; Lung; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; CIGARETTE SMOKE; EARLY GROWTH RESPONSE FACTOR 1; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN RECEPTOR; PROTEIN S 100; PROTEIN S100A12; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPOSURE; GENE EXPRESSION; GENETIC TRANSFECTION; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIGAND BINDING; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; LUNG; METABOLISM; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SMOKING;

ANIMALS; CELL LINE; EARLY GROWTH RESPONSE PROTEIN 1; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LUNG; MICE; NUCLEAR PROTEINS; RATS; RECEPTORS, IMMUNOLOGIC; RESPIRATORY MUCOSA; SMOKING; TRANSCRIPTION FACTORS;

EID: 48949119346     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00318.2007     Document Type: Article

References (46)

1. Abel M, Ritthaler U, Zhang Y, Deng Y, Schmidt AM, Greten J, Sernau T, Wahl P, Andrassy K, Ritz E. Expression of receptors for advanced glycosylated end-products in renal disease. Nephrol Dial Transplant 10, 1662-167, 1995.
2. Arumugam T, Simeone Van Golen K DM, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11: 5356-5364, 2005.
3. Baron V, Duss S, Rhim J, Mercola D. Antisense to early growth response gene-1 (Egr-1) inhibits prostate tumor development in TRAMP mice. Ann NY Acad Sci 1002: 197-216, 2003.
4. Beckmann AM, Wilce PA. Egr transcription factors in the nervous system. Neurochem Int 31: 477-510, 1997.
5. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50: 2792-2808, 2001.
6. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 289: F645-F659, 2005.
7. Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber EP. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res 323: 475-488, 2006.
8. Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 50: 191-224, 1995.
9. Greten J, Kreis I, Wiesel K, Stier E, Schmidt AM, Stern DM, Ritz E, Waldherr R, Nawroth PP. Receptors for advance glycation end-products (AGE): expression by endothelial cells in non-diabetic uraemic patients. Nephrol Dial Transplant 11: 786-790, 1996.
10. Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, Ghezzo H, Triantafillopoulos A, Whittaker K, Hoidal JR, Cosio MG. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 170: 974-980, 2004.
11. Gumbiner BM. Epithelial morphogenesis. Cell 69: 385-387, 1992.
12. Hislop A. Developmental biology of the pulmonary vasculature. Paediatr Respir Rev 6: 35-43, 2005.
13. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901, 1999.
14. Huttunen HJ, Fages C, Rauvala, H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kB required the cytoplasmic domain of the receptor but different downstream signaling pathway. J Biol Chem 274: 19919-19924, 1999.
15. Katz J, Stavropoulos F, Bhattacharyya I, Stewart C, Perez FM, Caudle RM. Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjogren's syndrome: a preliminary study. Scand J Rheumatol 33: 174-178, 2004.
16. Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res 98: 186-191, 2006.
17. Khachigian L, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 81: 457-461, 1997.
18. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ. The T-EBP null mouse: thyroid-specific enhanser-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10: 60-69, 1996.
19. Koslowski R, Barth K, Augstein A, Tschernig T, Bargsten G, Aufderheide M, Kasper M. A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression. Histochem Cell Biol 121: 509-519, 2004.
20. Lee S, Sadovsky Y, Swirnoff A, Polish J, Goda PG, Milbrandt J. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273: 1219-1221, 1996.
21. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5: 3-28, 1998.
22. Maeda Y, Dave V, Whitsett JA. Transcriptional control of lung morphogenesis. Physiol Rev 87: 219-244, 2007.
23. Molfino NA. Genetics of COPD. Chest 125: 1929-1940, 2004.
24. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YCE, Elliston K, Stern D, Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992.
25. Nicholl ID, Bacala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol 44: 1025-1033, 1998.
26. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4: 594-601, 1998.
27. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci 22: 167-173, 1999.
28. Reynolds PR, Hoidal JR. Cigarette smokeiInduced Egr-1 upregulates pro-inflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol 35: 314-319, 2006.
29. Reynolds PR, Hoidal JR. Temporal-spatial expression and transcriptional regulation of alpha7 nicotinic acetylcholine receptor by thyroid transcription factor-1 and early growth response factor-1 during murine lung development. J Biol Chem 280: 32548-32554, 2005.
30. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 37124-37132, 2004.
31. Riuzzi F, Sorci G, Donato R. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.J Biol Chem 281: 8242-8253, 2006.
32. Rong LL, Yan SF, Wendt T, Hans D, Pachydaki S, Bucciarelli LG, Adebayo A, Qu W, Lu Y, Kostov K, Lalla E, Yan SD, Gooch C, Szabolcs M, Trojaborg W, Hays AP, Schmidt AM. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB J 18: 1818-1825, 2004.
33. Schmidt AM, Stern DM. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab 11: 368-375, 2000.
34. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-955, 2001.
35. Silverman ES, Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol 154: 665-670, 1999.
36. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C. Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases. Nat Lond 405: 354-360, 2000.
37. Takeuchi M, Yamagishi S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Med Hypotheses 63: 449-452, 2004.
38. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275: 25781-25790, 2000.
39. Ten Have-Opbroek AAW. Lung development in the mouse embryo. Exp Lung Res 17: 111-130, 1991.
40. Thornally PJ. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classsification of AGEs. Cell Mol Biol 44: 1013-1023, 1998.
41. Topilko P, Schneider-Maunoury S, Levi G, Trembleau A, Gourdji D, Driancourt MA, Rao CV, Charnay P. Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 12: 107-122, 1998.
42. Warburton D, Wuenschell C, Flores-Delgado G, Anderson 1998 K. Commitment and differentiation of lung cell lineages. Biochem Cell Biol 76: 971-995, 1998.
43. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Nagashima M, Morser J, Migheli A. RAGE and amyloid beta peptide neurotoxicity in Alzheimer's disease. Nat Lond 382: 685-691, 1996.
44. Zaiou M, Azrolan N, Hayek T, Wang H, Wu L, Haghpassand M, Cizman B, Madaio M, Milbrandt J, Marsh J, Breslow J, Fisher E. The full induction of human apoA-1 gene expression by experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor Egr-1. J Clin Invest 101: 1699-1707, 1998.
45. Zhou Z, Immel D, XICX, Bierhaus A, Feng X, Mei L, Nawroth P, Stern DM, Xiong WC. Regulation of osteoclast function in bone mass by RAGE. J Exp Med 203: 1067-1080, 2006.
46. Zhu YK, Liu X, Ertl RF, Kohyama T, Wen FQ, Wang H, Spurzem JR, Romberger DJ, Rennard S. Retinoic acid attenuates cytokine-driven fibroblast degradation of extracellular matrix in three-dimensional culture. Am J Respir Cell Mol Biol 25: 620-627, 2001.